Paper7008932
Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.
Fisher B. Cancer Res, 1980. Cited by 339 papers, by iCite.
Cite this record
ConductScience Library. Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. Papers, record 7008932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7008932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Age Factors | |
| Female | |
| Humans | |
| Lymph Node Excision | |
| Lymph Nodes | |
| Lymphatic Metastasis | |
| Mastectomy | |
| Research Design |
Source PubMed
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 339 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488634 | Survival outcomes of axillary de-escalation following neoadjuvant chemo-immunotherapy in clinically node-positive triple-negative breast cancer: a national cancer database study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488634 | PubMed |
| 42213262 | The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42213262 | PubMed |
| 41815550 | De-escalating breast and axillary surgery in breast cancer: evidence, controversies, and future directions. | Front Oncol | 2026 | https://conductscience.org/library/papers/41815550 | PubMed |
| 41580815 | Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies. | J Transl Med | 2026 | https://conductscience.org/library/papers/41580815 | PubMed |
| 40772038 | Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining. | Front Oncol | 2025 | https://conductscience.org/library/papers/40772038 | PubMed |
| 40263543 | Evolutionary paths towards metastasis. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/40263543 | PubMed |
| 39953281 | Lymph node yield as a surrogate marker for tumour biology and prognosis in colon cancer. | Br J Cancer | 2025 | https://conductscience.org/library/papers/39953281 | PubMed |
| 39717616 | The History of Breast Cancer Early Detection: 1865 - 2020. | Breast Cancer (Dove Med Press) | 2024 | https://conductscience.org/library/papers/39717616 | PubMed |
| 39570418 | [Detection of circulating tumor cells in women with early breast cancer]. | Rev Med Inst Mex Seguro Soc | 2024 | https://conductscience.org/library/papers/39570418 | PubMed |
| 39037646 | Clinical Tumor Dormancy. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39037646 | PubMed |
| 38940900 | Cancer metastasis through the lymphatic versus blood vessels. | Clin Exp Metastasis | 2024 | https://conductscience.org/library/papers/38940900 | PubMed |
| 38730576 | Axillary Surgery for Breast Cancer in 2024. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38730576 | PubMed |
| 38248105 | Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38248105 | PubMed |
| 37415650 | Treatment Changes in Breast Cancer Management and De-Escalation of Breast Surgery. | Eur J Breast Health | 2023 | https://conductscience.org/library/papers/37415650 | PubMed |
| 37149414 | Lymph nodes: at the intersection of cancer treatment and progression. | Trends Cell Biol | 2023 | https://conductscience.org/library/papers/37149414 | PubMed |
| 37106239 | Local treatment in oligometastasis from breast cancer: an overview. | Clin Transl Oncol | 2023 | https://conductscience.org/library/papers/37106239 | PubMed |
| 36826153 | Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36826153 | PubMed |
| 36826069 | Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36826069 | PubMed |
| 36087082 | Five decades of progress in surgical oncology: Breast. | J Surg Oncol | 2022 | https://conductscience.org/library/papers/36087082 | PubMed |
| 35756663 | Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review. | Front Oncol | 2022 | https://conductscience.org/library/papers/35756663 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7008932
GET https://conductscience.org/api/papers/v1/7008932/cited_by?page=2